DOI: 10.1177/21621918261474733 ISSN: 2162-1918

Reimagining VEGF Therapy: The Role of PLCγ2 in Pan-Organ Endothelial Networks

Ahmed S. Abouhashem, Sumit S. Verma, Julie Faden-McCormack, Yomna A. Moqidem, Partha Dutta, Chandan K. Sen, Kanhaiya Singh
Show PDF Cite

Objective:

Ischemic tissue perfusion remains a major clinical challenge despite VEGF’s central role in angiogenesis. Limited success of VEGF-based therapies underscores the need to understand endothelial heterogeneity, as distinct subsets exhibit differential responsiveness. This study explores conserved endothelial states that govern VEGF-driven angiogenesis across human organs and evaluates their functional significance.

Approach:

We performed single-cell and single-nucleus RNA-sequencing (scRNA-seq/snRNA-seq) analysis of endothelial cells (ECs) from eight human tissues using GTEx data, validated findings in independent skin and heart datasets, and conducted CRISPR-mediated PLCγ2 knockout in cultured ECs followed by scRNA-seq.

Results:

Analysis of 209,126 nuclei revealed a universal arterial-like endothelial subset (cluster 2) enriched across all organs, characterized by high expression of PLCγ2 , a critical VEGF signaling effector. PLCγ2 high cells exhibited robust angiogenic and lymphangiogenic programs, including upregulation of VEGFC , NOTCH4 , and JAG1 , and enrichment of pathways for vasculature development and endothelial differentiation. Cell–cell communication analysis demonstrated exclusive BMP6, IGF2, and CXCL12 signaling from PLCγ2 high cells to fibroblasts, pericytes, and immune cells, positioning this subset as a central angiogenic hub. Functional validation showed that PLCγ2 knockout depleted PLCγ2 high clusters, suppressed VEGF signaling, and diminished BMP6 ligand secretion, confirming its role in maintaining proangiogenic endothelial states.

Innovation:

Ineffective targeting of the appropriate EC state may limit current therapeutic VEGF strategies, positioning PLCγ2 high ECs as a clinically relevant target.

Conclusion:

We identify PLCγ2 high arterial ECs as a conserved pan-organ population critical for VEGF responsiveness and vascular regeneration. These findings reimagine VEGF therapy by highlighting PLCγ2 as a critical regulator of a proangiogenic arterial-like endothelial state and a promising combinatorial target to overcome limitations of current angiogenic strategies.

More from our Archive